Vallon Pharmaceuticals (NASDAQ:VLON) will report on Q2 2021.
Barclays Maintains Overweight on PepsiCo, Raises Price Target to $168
Barclays analyst Lauren Lieberman maintains PepsiCo (NASDAQ:PEP) with a Overweight and raises the price target from $165 to $168.